Validation and quality control of replacement alternatives - Current status and future challenges

Toxicology Research

Volumn 1, Issue 1, 2012, Pages 8-22

  Leist, Marcel ^a   Hasiwa, Nina ^a   Daneshian, Mardas ^a   Hartung, Thomas ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; BACTERIAL VACCINE; BIOLOGICAL PRODUCT; CALCITONIN; CHEMICAL COMPOUND; COSMETIC; CYTOCHROME P450; DIPHTHERIA VACCINE; ENDOCRINE DISRUPTOR; HEPATITIS B VACCINE; NANOPARTICLE; ORAL POLIOMYELITIS VACCINE; PESTICIDE; POLIOMYELITIS VACCINE; PYROGEN; SWINE ERYSIPELAS VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; VACCINE;

ACUTE TOXICITY; ANALYTIC METHOD; ANIMAL TESTING ALTERNATIVE; BLOOD TOXICITY; CARCINOGENICITY; CELL LINE; CELL VIABILITY; CHEMICAL ANALYSIS; CHRONIC TOXICITY; CYTOTOXICITY; DATA ANALYSIS; DEVELOPMENT; DEVELOPMENTAL TOXICITY; DRUG POTENCY; DRUG SAFETY; ECOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME METABOLISM; EYE IRRITATION; FOOD SAFETY; GENOTOXICITY; GOOD LABORATORY PRACTICE; GOVERNMENT; HAZARD RATIO; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHOTOTOXICITY; POLLUTION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; SCIENTIFIC LITERATURE; SKIN SENSITIZATION; SKIN TEST; TETANUS TOXOID ELISA KIT; THEORETICAL MODEL; TOXICITY TESTING; TOXICOKINETICS; TOXICOLOGICAL PARAMETERS; VACCINATION; VALIDATION PROCESS;

ANIMALIA;

EID: 84864593532     PISSN: 2045452X     EISSN: 20454538     Source Type: Journal    
DOI: 10.1039/c2tx20011b     Document Type: Review

References (175)

1. T. Hartung Food for thought. on validation ALTEX 2007 24 2 67 80
2. M. Daneshian et al. A framework program for the teaching of alternative methods (replacement, reduction, refinement) to animal experimentation ALTEX 2011 28 4 341 352
3. C. Burgess, Valid Analytical Methods and Procedures, Royal Society of Chemistry, 1st edn, 2001
4. T. Hartung et al. Good cell culture practice. ECVAM good cell culture practice task force report 1 Altern. Lab. Anim. 2002 30 4 407 414
5. S. Coecke et al. Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice Altern. Lab. Anim. 2005 33 3 261 287 (Pubitemid 40964979)
6. L. A. Knight I. A. Cree Quality assurance and good laboratory practice Methods Mol. Biol. (Totowa, N. J.) 2011 731 115 124
7. T. Hartung Evidence-based toxicology - the toolbox of validation for the 21st century? ALTEX 2010 27 4 253 263
8. T. Hartung et al. A modular approach to the ECVAM principles on test validity Altern. Lab. Anim. 2004 32 5 467 472 (Pubitemid 40128842)
9. S. Creton et al., Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs Mutagenesis 2011
10. R. L. Kodell et al., Hierarchical models for probabilistic dose-response assessment Regul. Toxicol. Pharmacol. 2006 45 3 265 272 (Pubitemid 44066628)
11. P. B. Kuegler et al., Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing ALTEX 2010 27 1 17 42
12. N. V. Stiegler et al., Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures Toxicol. Sci. 2011 121 1 73 87
13. C. Volbracht M. Leist P. Nicotera ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium deprivation Mol. Med. 1999 5 7 477 489 (Pubitemid 29399753)
14. J. Lotharius et al., Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway J. Neurosci. 2005 25 27 6329 6342 (Pubitemid 40962528)
15. O. Hansson et al., Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression Brain Res. 2003 970 1-2 47 57 (Pubitemid 36423181)
16. M. Leist L. Efremova C. Karreman Food for thought... considerations and guidelines for basic test method descriptions in toxicology ALTEX 2010 27 4 309 317
17. M. Balls et al., The principles of weight of evidence validation of test methods and testing strategies, The report and recommendations of ECVAM workshop 58 Altern. Lab. Anim. 2006 34 6 603 620 (Pubitemid 46238600)
18. M. Leist T. Hartung P. Nicotera The dawning of a new age of toxicology ALTEX 2008 25 2 103 114
19. Y. Benjamini et al., Controlling the false discovery rate in behavior genetics research Behav. Brain Res. 2001 125 1-2 279 284 (Pubitemid 33000466)
20. T. Hartung Comparative analysis of the revised Directive 2010/63/EU for the protection of laboratory animals with its predecessor 86/609/EEC - a t4 report ALTEX 2010 27 4 285 303
21. C. Rovida Food for thought... why no new in vitro tests will be done for REACH by registrants ALTEX 2010 27 3 175 183
22. M. Bahramsoltani et al., Quantitation of angiogenesis and antiangiogenesis in vivo, ex vivoin vitro - an overview ALTEX 2009 26 2 95 107
23. T. Lindl M. Voelkel No clinical relevance of approved animal experiments after seventeen years ALTEX 2011 28 3 242 243
24. M. E. Andersen Calling on science: making "alternatives" the new gold standard ALTEX 2010 27 29 37
25. N. Hasiwa et al., Critical evaluation of the use of dogs in biomedical research and testing in Europe ALTEX 2011 28 4 326 340
26. J. Zurlo Critical evaluation of the use of dogs in biomedical research and testing ALTEX 2011 8 4 355 359
27. T. Hartung Food for thought... on animal tests ALTEX 2008 25 1 3 16
28. C. Westmoreland et al., Assuring safety without animal testing: Unilever's ongoing research programme to deliver novel ways to assure consumer safety ALTEX 2010 27 3 61 65
29. S. Hoffmann et al., Points of reference in the validation process: the report and recommendations of ECVAM Workshop 66 Altern. Lab. Anim. 2008 36 3 343 352
30. M. Daneshian M. Leist T. Hartung The center for alternatives to animal testing - Europe (CAAT-EU): a transatlantic bridge for the paradigm shift in toxicology ALTEX 2010 27 1 63 69
31. D. A. Basketter et al., A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report* ALTEX 2012 29 1 3 91
32. C. Rauch et al., Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media ALTEX 2011 28 4 305 316
33. D. Brunner et al., Serum-free cell culture: the serum-free media interactive online database ALTEX 2010 27 1 53 62
34. J. van der Valk et al., Optimization of chemically defined cell culture media - replacing fetal bovine serum in mammalian in vitro methods Toxicol In Vitro 2010 24 4 1053 1063
35. M. Hamann et al., Non-invasive genotyping of transgenic mice: comparison of different commercial kits and required amounts ALTEX 2010 27 3 185 190
36. J. Stracke et al., Assessment of stress in laboratory beagle dogs constrained by a Pavlov sling ALTEX 2011 28 4 317 325
37. OECD, OECD Guidelines for the Testing of Chemicals, Homepage. 2012 [cited 2012; Available from: http://www.oecd.org/document/7/0,3343,en-2649-34377- 37051368-1-1-1-1,00.html
38. T. Hartung Food for thought. on alternative methods for chemical safety testing ALTEX 2010 27 1 3 14
39. EDQM. European Pharmacopeia 7th Edition, Homepage. 2012; Available from: http://www.edqm.eu/en/European-Pharmacopoeia-1401.html
40. EPA. About the Office of Chemical Safety and Pollution Prevention (OCSPP), Homepage. 2012; Available from: http://www.epa.gov/aboutepa/ocspp.html
41. EPA. Health Effects Test Guideline, OPPTS 870.2600. Skin Sensitization EPA 712-C-03-197. Washington, DC: U.S. Environmental Protection Agency, 2003 [cited 2012; Available from: http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/EPA/ EPa870r-2600.pdf
42. H. Kandarova S. Letasiova Alternative methods in toxicology: pre-validated and validated methods Interdiscip. Toxicol. 2011 4 3 107 113
43. OECD, Test No. 203: Fish, Acute Toxicity Test, OECD Guidelines for the Testing of Chemicals, Section 2, OECD Publishing, 1992, 10.1787/9789264069961-en
44. T. H. Hutchinson et al., A strategy to reduce the numbers of fish used in acute ecotoxicity testing of pharmaceuticals Environ. Toxicol. Chem. 2003 22 12 3031 3036 (Pubitemid 37485236)
45. S. Jeram et al., A strategy to reduce the use of fish in acute ecotoxicity testing of new chemical substances notified in the European Union Regul. Toxicol. Pharmacol. 2005 42 2 218 224 (Pubitemid 40826567)
46. ECVAM, ESAC Statement on the scientific validity of the upper threshold concentration (UTC) step-down approach - A new testing strategy to reduce the use of fish in acute aquatic toxicity testing, 2006
47. I. W. Selderslaghs et al., Locomotor activity in zebrafish embryos: a new method to assess developmental neurotoxicity Neurotoxicol. Teratol. 2010 32 4 460 471
48. I. W. Selderslaghs et al., Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo Reprod. Toxicol. 2009 28 3 308 320
49. T. Seidle P. Prieto A. Bulgheroni Examining the regulatory value of multi-route mammalian acute systemic toxicity studies ALTEX 2011 28 2 95 102
50. OECD, Test No. 420: Acute Oral Toxicity - Fixed Dose Procedure, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 2002, 10.1787/9789264070943-en
51. OECD, Test No. 423: Acute Oral toxicity - Acute Toxic Class Method, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 2002, 10.1787/9789264071001-en
52. M. J. van den Heuvel et al. The international validation of a fixed-dose procedure as an alternative to the classical LD50 test Food Chem. Toxicol. 1990 28 7 469 482 (Pubitemid 20329374)
53. E. Schlede et al., The international validation study of the acute toxic class method (oral) Arch. Toxicol. 1995 69 10 659 670
54. W. Diener E. Schlede Acute toxic class methods: alternatives to LD/LC50 tests ALTEX 1999 16 3 129 134
55. E. Schlede et al., A national validation study of the acute-toxic-class method - an alternative to the LD50 test Arch. Toxicol. 1992 66 7 455 470
56. M. D. Bethesda, Guidance document on using in vitro data to estimate starting doses for acute toxicity, in 01-4500, ICCVAM, Editor, NIH, 2001
57. W. S. Stockes and L. Schechtman, In vitro cytotoxicity test methods for estimating starting doses for acute oral systemic toxicity tests, in ICCVAM Test Method Evaluation REPORT, ICCVAM, 2006
58. A. Schrage et al., Refinement and reduction of acute oral toxicity testing: a critical review of the use of cytotoxicity data Altern. Lab. Anim. 2011 39 3 273 295
59. OECD, Test No. 403: Acute Inhalation Toxicity, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 2009, 10.1787/9789264070608-en
60. S. Bitz The botulinum neurotoxin LD50 test - problems and solutions ALTEX 2010 27 2 114 116
61. M. D. Bethesda, Report on the ICCVAM-NICEATM/ECVAM scientific workshop on alternative methods to refine, reduce or replace the mouse LD50 assay for botulinum toxin testing, in 08-6416, NIH, Editor 2008, NIH
62. T. A. Ekong I. M. Feavers D. Sesardic Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro Microbiology 1997 143 Pt 10 3337 3347 (Pubitemid 27470183)
63. R. E. Gaines Das et al., Validation of in vitro assays for botulinum toxin: a case study Dev. Biol. Stand. 1999 101 267 276
64. D. Sesardic et al., Detection of antibodies against botulinum toxins Mov. Disord. 2004 19 Suppl 8 S85 S91
65. T. Hartung Three Rs potential in the development and quality control of pharmaceuticals ALTEX 2001 18 Suppl 1 3 13
66. P. P. Pastoret et al., New vaccine production technologies and their impact on the use of animals Dev. Biol. (Basel) 2002 111 219 220
67. U. Rosskopf-Streicher et al., Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test Vaccine 2001 19 11-12 1477 1483 (Pubitemid 32332733)
68. U. Rosskopf-Streicher et al., Potency testing of swine erysipelas vaccines by serology results of a pre-validation study ALTEX 1999 16 3 123 128
69. M. Balls and E. Hellsten, Statement on the application of the ELISA procedure for batch potency testing of tetanus vaccines for human use, I.f.H.C.P. Joint Research Centre, ECVAM Unit, Editor 2000, European Commission, Ispra
70. M. Balls and E. Hellsten, Statement on the application of the TOBI test for batch potency testing of tetanus vaccines for human use, I.f.H.C.P. Joint Research Centre, ECVAM Unit, Editor 2000, European Commission, Ispra
71. Council-of-Europe, ed. 2.7.6 Assay of diphtheria vaccine (adsorbed), 01/2005:20706. European Pharmacopoeia, 6th edn, Council of Europe, Strasbourg, France, 2008, vol. 2.7.6
72. M. Schwanig et al., Elimination of abnormal toxicity test for sera and certain vaccines in the European Pharmacopoeia Vaccine 1997 15 10 1047 1048 (Pubitemid 27357185)
73. WHO, Final Report: IABS Scientific Workshop on Neurovirulence Tests of Live Virus Vaccines, Geneva, Switzerland, 2005, p. 7
74. E. Dragunsky et al., Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study Bull World Health Organ. 2003 81 4 251 260 (Pubitemid 36542141)
75. OECD, Test No. 409: Repeated Dose 90-Day Oral Toxicity Study in Non-Rodents, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264070721-en, 1998
76. OECD, Test No. 437: Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264076303-en, 2009
77. OECD, Test No. 438: Isolated Chicken Eye Test Method for Identifying Ocular Corrosives and Severe Irritants, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264076310-en, 2009
78. OECD. Draft OECD Guideline for the Testing of Chemicals: The Cytosensor Microphysiometer Test Method: An In Vitro Method for Identifying Chemicals Not Classified as Irritant, as well as Ocular Corrosive and Severe Irritant Chemicals, 2010, Available from: http://www.oecd.org/dataoecd/17/43/46784020.pdf
79. OECD. Draft OECD Guideline for the Testing of Chemicals: Fluorescein Leakage Test Method for Identifying Ocular Corrosives and Severe Irritants, 2010, Available from: http://www.oecd.org/dataoecd/17/44/46784112.pdf
80. T. Hartung et al., First alternative method validated by a retrospective weight-of-evidence approach to replace the Draize eye test for the identification of non-irritant substances for a defined applicability domain ALTEX 2010 27 1 43 51
81. P. McNamee, et al., Update on the Colipa research programme for development of in vitro alternative methods for eye irritation, in 6th World Congress on Alternatives & Animal Use in the Life Sciences, Tokyo, Japan, 2007
82. L. Scott et al., A proposed eye irritation testing strategy to reduce and replace in vivo studies using bottom-up and top-down approaches Toxicol. In Vitro 2010 24 1 1 9
83. J. F. Jellett et al., Detection of paralytic shellfish poisoning (PSP) toxins in shellfish tissue using MIST Alert, a new rapid test, in parallel with the regulatory AOAC mouse bioassay Toxicon. 2002 40 10 1407 1425 (Pubitemid 35284041)
84. F. H. Mackintosh et al., Assessment of MIST Alert, a commercial qualitative assay for detection of paralytic shellfish poisoning toxins in bivalve molluscs J. AOAC Int. 2002 85 3 632 641
85. FAO/IOC/WHO, Report of the joint FAO/IOC/WHO ad hoc expert consultation on biotoxins in bivalve molluscs, Oslo, Norway, 2004, pp. 26 30
86. P. Vanparys et al., ECVAM prevalidation of three cell transformation assays ALTEX 2011 28 1 56 9
87. R. Combes et al., Cell transformation assays as predictors of human carcinogenicity - the report of ECVAM workshop 39 ATLA 1999 27 745 767 (Pubitemid 29503028)
88. D. Maurici et al., Carcinogenicity Altern. Lab. Anim. 2005 33 Suppl 1 177 182
89. OECD, Detailed review paper on cell transformation assays for detection of chemical carcinogens, OECD Environment, Health and Safety Publications Series on Testing and Assessment No. 31, ENV/JM/MONO(2007)18, 2007, 170
90. OECD, Test No. 471: Bacterial Reverse Mutation Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071247-en, 1997
91. OECD, Test No. 480: Genetic Toxicology: Saccharomyces cerevisiae, Gene Mutation Assay, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071407-en, 1986
92. OECD, Test No. 481: Genetic Toxicology: Saccharomyces cerevisiae, Miotic Recombination Assay, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071421-en, 1986
93. OECD, Test No. 473: In vitro Mammalian Chromosome Aberration Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071261-en, 1997
94. OECD, Test No. 476: In vitro Mammalian Cell Gene Mutation Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071322-en, 1997
95. OECD, Test No. 479: Genetic Toxicology: In vitro Sister Chromatid Exchange Assay in Mammalian Cells, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071384-en, 1986
96. OECD, Test No. 482: Genetic Toxicology: DNA Damage and Repair, Unscheduled DNA Synthesis in Mammalian Cells in vitro, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071445-en, 1986
97. OECD, Test No. 487: In Vitro Mammalian Cell Micronucleus Test; 10.1787/9789264091016-en, 2010
98. M. Moreno-Villanueva et al., The automated FADU-assay, a potential high-throughput in vitro method for early screening of DNA breakage ALTEX 2011 28 4 295 303
99. A. Pessina et al., Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics Toxicol. Sci. 2003 75 2 355 367 (Pubitemid 37220283)
100. M. Schulz et al., Toxicity assessment of waste water samples with fish cell lines ALTEX 1995 12 4 188 195
101. OECD, Test No. 432: In Vitro 3T3 NRU Phototoxicity Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071162- en, 2004
102. ECVAM. ESAC Statement on the validity of in-vitro pyrogen tests, 2006 [cited 2012; Available from: http://ecvam.jrc.it/ft-doc/ESAC statement pyrogenicity 20060516.pdf]
103. J. A. Troutman et al., The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments Toxicol. Sci. 2011 122 2 422 436
104. NICEATM-ICCVAM, Independent Peer Review Panel Report: Five In Vitro Test Methods Proposed for Assessing Potential Pyrogenicity of Pharmaceuticals and Other Products. http://iccvam.niehs.nih.gov/docs/pyrogen/PrRevPanFinRpt.pdf, 2007
105. NICEATM-ICCVAM, ICCVAM Background Review Document: Validation Status of Five In Vitro Test Methods Proposed for Assessing Potential Pyrogenicity of Pharmaceuticals and Other Products, 71003, in Federal Register, 2008
106. NICEATM-ICCVAM. In Vitro Pyrogen Test Methods: Overview and Recommendations. 2009; Available from: http://iccvam.niehs.nih.gov/methods/ pyrogen/pyrogen.htm
107. S. Poole et al., A rapid 'one-plate' in vitro test for pyrogens J. Immunol. Methods 2003 274 1-2 209 220 (Pubitemid 36263056)
108. S. Hoffmann et al., International validation of novel pyrogen tests based on human monocytoid cells J. Immunol. Methods 2005 298 1-2 161 173 (Pubitemid 40545102)
109. S. Hoffmann et al., Optimisation of pyrogen testing in parenterals according to different pharmacopoeias by probabilistic modelling J. Endotoxin. Res. 2005 11 1 25 31 (Pubitemid 40533076)
110. R. Perdomo-Morales et al., Monocyte activation test (MAT) reliably detects pyrogens in parenteral formulations of human serum albumin ALTEX 2011 28 3 227 235
111. OECD, Test No. 415: One-Generation Reproduction Toxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264070844-en, 1983
112. OECD, Test No. 443: Extended One-Generation Reproductive Toxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264122550-en, 2008
113. ECVAM. The Micromass Test - Method of Brown: INVITTOX no. 122. Embryotoxicity/Teratogenicity. 2006
114. H. Spielmann et al., The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM/ZEBET workshop (ECVAM workshop 57) Altern. Lab. Anim. 2006 34 5 527 538
115. ECVAM, Embryonic Stem Cell Test (EST): INVITTOX no. 113. Embryotoxicity/Teratogenicity, 2002
116. C. Rovida F. Longo R. R. Rabbit How are reproductive toxicity and developmental toxicity addressed in REACH dossiers? ALTEX 2011 28 4 273 294
117. OECD, Test No. 455: The Stably Transfected Human Estrogen Receptor-alpha Transcriptional Activation Assay for Detection of Estrogenic Agonist-Activity of Chemicals, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264076372-en, 2009
118. OECD, Test No. 456: H295R Steroidogenesis Assay, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264122642-en, 2011
119. EPA, OCSPP Harmonized Test Guidelines, Series 890 - Endocrine Disruptor Screening Program Test Guidelines, 2012
120. OECD, Test No. 428: Skin Absorption: In Vitro Method, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071087-en, 2004
121. OECD. OECD Guidance on dermal absorption. 2010 [cited 2012; Available from: http://www.oecd.org/dataoecd/0/1/46257610.pdf]
122. OECD, Test No. 430: In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test (TER), OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071124-en, 2004
123. OECD, Test No. 431: In Vitro Skin Corrosion: Human Skin Model Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071148-en, 2004
124. OECD, Test No. 435: In Vitro Membrane Barrier Test Method for Skin Corrosion, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264067318-en, 2006
125. OECD, Test No. 439: In Vitro Skin Irritation Reconstructed Human Epidermis Test Method, 10.1787/9789264090958-en, 2010
126. OECD, Test No. 429: Skin Sensitisation: Local Lymph Node Assay, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 10.1787/9789264071100-en, 2002
127. NICEATM-ICCVAM. The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds. The Results of an Independent Peer Review Evaluation. 1999 [cited 2012; Available from: http://iccvam.niehs.nih.gov/docs/immunotox-docs/llna/llnarep.pdf
128. ISO, ISO 10993-10:2010, Biological evaluation of medical devices - Part 10: Tests for irritation and delayed type hypersensitivity, 2002
129. ECVAM. ESAC Statement on the Validity of the Local Lymph Node Assay for Skin Sensitisation Testing. 2000 [cited 2012; Available from: http://ecvam.jrc.it/page-pdf.cfm?voce=s&idvoce=27]
130. ECVAM. ESAC Statement on the reduced local lymph node assay (rLLNA). 2007; Available from: http://ecvam.jrc.it/page-pdf.cfm?voce=s&idvoce=27
131. C. Rovida Local lymph node assay: how testing laboratories apply OECD TG 429 for REACH purposes ALTEX 2011 28 2 117 129
132. G. Maxwell et al., Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment ALTEX 2011 28 1 50 55
133. J. Jaworska et al., Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept case ALTEX 2011 28 3 211 225
134. S. Adler et al., Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010 Arch. Toxicol. 2011 85 5 367 485
135. K. Taylor C. Casalegno W. Stengel A critique of the EC's expert (draft) reports on the status of alternatives for cosmetics testing to meet the 2013 deadline ALTEX 2011 28 2 131 148
136. T. Hartung et al., An expert consortium review of the EC-commissioned report "alternative (non-animal) methods for cosmetics testing: current status and future prospects - 2010" ALTEX 2011 28 3 183 209
137. U. G. Sauer Animal and non-animal experiments in nanotechnology - the results of a critical literature survey ALTEX 2009 26 2 109 128
138. U. G. Sauer Political incentives towards replacing animal testing in nanotechnology? ALTEX 2009 26 4 285 294
139. E. K. Silbergeld et al. t4 Workshop Report: Nanotoxicology: "the end of the beginning" - signs on the roadmap to a strategy for assuring the safe application and use of nanomaterials ALTEX 2011 28 3 236 241
140. T. Hartung Food for thought. on alternative methods for nanoparticle safety testing ALTEX 2010 27 2 87 95
141. P. Marx-Stoelting et al., A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM/ReProTect workshop Altern. Lab. Anim. 2009 37 3 313 328
142. E. van Vliet Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century ALTEX 2011 28 1 17 44
143. T. Hartung M. McBride Food for thought... on mapping the human toxome ALTEX 2011 28 2 83 93
144. M. T. Cronin et al., Formation of mechanistic categories and local models to facilitate the prediction of toxicity ALTEX 2011 28 1 45 49
145. K. Boekelheide M. E. Andersen A mechanistic redefinition of adverse effects - a key step in the toxicity testing paradigm shift ALTEX 2010 27 4 243 252
146. M. E. Andersen et al., Can case study approaches speed implementation of the NRC report: "toxicity testing in the 21st century: a vision and a strategy?" ALTEX 2011 28 3 175 182
147. S. Lund et al., The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions J. Neuroimmunol 2006 180 1-2 71 87 (Pubitemid 44692327)
148. S. Coecke et al., Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies Environ. Health Perspect. 2007 115 6 924 931 (Pubitemid 46902248)
149. D. R. Dietrich Courage for simplification and imperfection in the 21st century assessment of "Endocrine disruption" ALTEX 2010 27 4 264 278
150. J. Jaworska S. Hoffmann Integrated Testing Strategy (ITS) - Opportunities to better use existing data and guide future testing in toxicology ALTEX 2010 27 4 231 242
151. A. Kinsner-Ovaskainen et al., Overcoming barriers to validation of non-animal partial replacement methods/integrated testing strategies: the report of an EPAA-ECVAM workshop Altern. Lab. Anim. 2009 37 4 437 444
152. K. M. Crofton et al., Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals ALTEX 2011 28 1 9 15
153. C. A. Boyle P. Decoufle M. Yeargin-Allsopp Prevalence and health impact of developmental disabilities in US children Pediatrics 1994 93 3 399 403 (Pubitemid 24067011)
154. P. Decoufle et al., Increased risk for developmental disabilities in children who have major birth defects: a population-based study Pediatrics 2001 108 3 728 734 (Pubitemid 32786605)
155. T. Schettler Toxic threats to neurologic development of children Environ. Health Perspect. 2001 109 Suppl 6 813 816 (Pubitemid 34059195)
156. B. M. Kuehn Increased risk of ADHD associated with early exposure to pesticides PCBs, JAMA 2010 304 1 27 8
157. S. K. Sagiv et al., Prenatal organochlorine exposure and behaviors associated with attention deficit hyperactivity disorder in school-aged children Am. J. Epidemiol. 2010 171 5 593 601
158. P. Grandjean P. J. Landrigan Developmental neurotoxicity of industrial chemicals Lancet 2006 368 9553 2167 2178 (Pubitemid 44894541)
159. S. L. Makris et al., A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426 Environ. Health Perspect. 2009 117 1 17 25
160. L. D. Middaugh et al., Neurobehavioral assessment: a survey of use and value in safety assessment studies Toxicol. Sci. 2003 76 2 250 261 (Pubitemid 38035418)
161. P. Lein P. Locke A. Goldberg Meeting report: alternatives for developmental neurotoxicity testing Environ. Health Perspect. 2007 115 5 764 768 (Pubitemid 46785047)
162. A. K. Bal-Price et al., In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints Neurotoxicology 2010 31 5 545 554
163. M. Leist et al., The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy ALTEX 2008 25 3 163 190
164. B. Zimmer et al. Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure Toxicol. Sci. 2011 121 2 357 367
165. B. Zimmer et al., Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing Cell Death Differ. 2011 18 3 383 395
166. S. Kadereit Z. B. Zimmer C. van Thriel J. G. Hengstler M. Leist Compound selection for in vitro models of developmental neurotoxicity and prenatal neurotoxicity Frontiers in Bioscience 2012 17 2442 2460
167. C. van Thriel et al., Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts Neurotoxicology 2011
168. J. G. Hengstler R. Marchan M. Leist Highlight report: towards the replacement of in vivo repeated dose systemic toxicity testing Arch. Toxicol. 2012 86 1 13 5
169. N. Wilcox A. Goldberg Food for thought... on validation. A puzzle or a mystery: an approach founded on new science ALTEX 2011 28 1 3 8
170. W. S. Stokes M. Wind Validation of innovative technologies and strategies for regulatory safety assessment methods: challenges and opportunities ALTEX 2010 27 3 87 95
171. S. Hoffmann T. Hartung Toward an evidence-based toxicology Hum. Exp. Toxicol. 2006 25 9 497 513 (Pubitemid 44409040)
172. T. Hartung Food for thought... on evidence-based toxicology ALTEX 2009 26 2 75 82
173. J. Zurlo Evidence-based toxicology collaboration, kick-off meeting ALTEX 2011 28 152
174. CAAT, 21st Century Validation Strategies for 21st Century Tools. ALTEX 2010; Available from: http://caat.jhsph.edu/programs/workshops/july13validation. html
175. D. Rudacille Summary of the July 2010 workshop, "21st century validation strategies for 21st century tools" ALTEX 2010 27